Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
Risk of cellular or antibody-mediated rejection in pediatric kidney transplant recipients with BK polyomavirus replication—an international CERTAIN registry study ; day:11 ; month:10 ; year:2024 ; pages:1-14
Pediatric nephrology ; (11.10.2024), 1-14
- Urheber
-
Fichtner, Alexander
Schmidt, Jeremy
Süsal, Caner
Carraro, Andrea
Oh, Jun
Zirngibl, Matthias
König, Sabine
Guzzo, Isabella
Weber, Lutz T.
Awan, Atif
Krupka, Kai
Schnitzler, Paul
Hirsch, Hans H.
Tönshoff, Burkhard
Höcker, Britta
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00467-024-06501-7
- URN
-
urn:nbn:de:101:1-2412302115174.339246141708
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:23 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Fichtner, Alexander
- Schmidt, Jeremy
- Süsal, Caner
- Carraro, Andrea
- Oh, Jun
- Zirngibl, Matthias
- König, Sabine
- Guzzo, Isabella
- Weber, Lutz T.
- Awan, Atif
- Krupka, Kai
- Schnitzler, Paul
- Hirsch, Hans H.
- Tönshoff, Burkhard
- Höcker, Britta
- SpringerLink (Online service)
Ähnliche Objekte (12)
Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis
Association of non-HLA antibodies against endothelial targets and donor-specific HLA antibodies with antibody-mediated rejection and graft function in pediatric kidney transplant recipients
Treatment of chronic active antibody-mediated rejection in renal transplant recipients – a single center retrospective study
Incidence, risk factors, management strategies, and outcomes of antibody-mediated rejection in pediatric kidney transplant recipients—a multicenter analysis of the Cooperative European Paediatric Renal Transplant Initiative (CERTAIN)
Antibody-mediated rejection of arterialised venous allografts is inhibited by immunosuppression in rats : Antibody-mediated rejection of arterialised venousallografts is inhibited by immunosuppression in rats
HLA antibody-mediated pathways in human endothelial cells and transplant rejection
Immunoproteasome inhibition prevents chronic antibody-mediated allograft rejection in renal transplantation
Clazakizumab for the treatment of chronic active antibody-mediated rejection (AMR) in kidney transplant recipients: Phase 3 IMAGINE study rationale and design
Daratumumab for Treatment of Antibody-Mediated Rejection after ABO-Incompatible Kidney Transplantation
Late antibody-mediated rejection in a kidney transplant recipient: COVID 19 induced?
BK Polyomavirus-specific T cell immune responses in kidney transplant recipients diagnosed with BK Polyomavirus-associated nephropathy
Validation of a molecular diagnostics for antibody-mediated rejection in human endomyocardial biopsies
Late antibody-mediated rejection after ABO-incompatible kidney transplantation during Gram-negative sepsis